(Q30433066)

21 June 2017

1 reference

title

Cutaneous hyperpigmentation caused by systemic drugs (English)

1 reference

21 June 2017

1 reference

Hendrix JD Jr

1

1 reference

PubMed ID

1500233

21 June 2017

Greer KE

series ordinal

2

1 reference

21 June 2017

1 July 1992

1 reference

International Journal of Dermatology

21 June 2017

1 reference

21 June 2017

31

1 reference

21 June 2017

7

1 reference

21 June 2017

458-466

1 reference

Pigmentation induced by quinidine therapy.

21 June 2017

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-4362.1992.TB02689.X

PIGMENTATION FROM ANTIMALARIAL THERAPY. ITS POSSIBLE RELATIONSHIP TO THE OCULAR LESIONS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-4362.1992.TB02689.X

Antimalarial agents. Chloroquine, hydroxychloroquine, and quinacrine

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-4362.1992.TB02689.X

Wood's light fluorescence phenomenon in quinacrine medication.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-4362.1992.TB02689.X

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-4362.1992.TB02689.X

Metabolism and tissue distribution of radioisotopically labeled minocycline

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-4362.1992.TB02689.X

Localized Hemosiderosis as a Sequela of Acne

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-4362.1992.TB02689.X

Skin pigmentation secondary to minocycline therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-4362.1992.TB02689.X

Ultrastructural and X-ray Microanalytical Observations of Minocycline-related Hyperpigmentation of the Skin

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-4362.1992.TB02689.X

Medicinal arsenic and internal malignancies

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-4362.1992.TB02689.X

Drug reactions. XXIV. Cutaneous reactions to cytostatic agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-4362.1992.TB02689.X

Acanthosis nigricans-like hyperpigmentation secondary to triazinate therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-4362.1992.TB02689.X

Cutaneous pigmented stripes and bleomycin treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-4362.1992.TB02689.X

Additive nephrotoxicity from roentgenographic contrast media. Its occurrence in phenazopyridine-induced acute renal failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-4362.1992.TB02689.X

Acute renal failure and pigmentation due to phenazopyridine (Pyridium).

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-4362.1992.TB02689.X

Side effects and possible contraindications of amiodarone use.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-4362.1992.TB02689.X

Oral mucosa pigmentation: a new side effect of azidothymidine therapy in patients with acquired immunodeficiency syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-4362.1992.TB02689.X

Steroid-Induced Acanthosis Nigricans in Dermatomyositis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-4362.1992.TB02689.X

10.1111/J.1365-4362.1992.TB02689.X

21 January 2018

Identifiers

DOI

1 reference

release_gpwepsetmzfdvlfb7txsnviiue

21 June 2017

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/gpwepsetmzfdvlfb7txsnviiue

mapped directly with Wikidata item

24 November 2022

based on heuristic

PubMed ID

1500233

1 reference

PubMed ID

1500233